This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Outlines the process of developing and managing an overdose prevention and education program, with or without a take-home naloxone component.
Provides guidelines that can improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose.
This HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics provides advice to clinicians who are contemplating or initiating a reduction in opioid dosage or discontinuation of long-term opioid thera
Identifies four key goal areas that address the epidemic in a comprehensive, multifaceted approach to support the plan’s 2022 vision of "A safe and healthy Idaho, free of opioid misuse and untreated opioid use disorders."
Offers a sample checklist for treatment program personnel who answer inquiries about buprenorphine/naloxone treatment.
As part of the Substance Use Disorder 101 Core Curriculum from PCSS, this module reviews and compares pharmacological treatment options for individuals with opioid use disorder, including methadone, buprenorphine (SL and injectable formulations), and naltrexone (oral and long-acting intramuscular formulations).
Email Updates